SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-015093
Filing Date
2020-08-10
Accepted
2020-08-10 16:15:44
Documents
92
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1399865
2 ex10-1.htm EX-10.1 106850
3 ex31-1.htm EX-31.1 19753
4 ex31-2.htm EX-31.2 19318
5 ex32-1.htm EX-32.1 7086
  Complete submission text file 0001493152-20-015093.txt   7923850

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hrow-20200630.xsd EX-101.SCH 63993
7 XBRL CALCULATION FILE hrow-20200630_cal.xml EX-101.CAL 80787
8 XBRL DEFINITION FILE hrow-20200630_def.xml EX-101.DEF 292839
9 XBRL LABEL FILE hrow-20200630_lab.xml EX-101.LAB 510041
10 XBRL PRESENTATION FILE hrow-20200630_pre.xml EX-101.PRE 404315
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1359995
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 201089560
SIC: 2834 Pharmaceutical Preparations